603707.SH
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 8.06
−0.74%Forward multiples
Based on analyst estimates
- P/E forward
- 17.57x
- P/E 2026E
- 20.20x
- P/E 2027E
- 16.32x
- P/E 2028E
- 12.34x
- P/S forward
- 3.26x
Trailing multiples
Trailing twelve months
- P/E TTM
- 22.39x
- PEG TTM
- 0.91x
- Price / book
- 1.88x
- Price / sales
- 3.24x
- Price / cash flow
- 8.54x
Enterprise value
- Enterprise value
- CNY 12.6B
- EV / sales
- 3.13x
- EV / EBITDA
- 13.36x
- EV / EBIT
- 17.86x
- Market cap
- CNY 13.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026